2017
B. Bódi, E. Pásztorné Tóth, L. Nagy, A. Tóth, L. Mártha, Á. Kovács, G. Balla, T. Kovács, Z. Papp. "Titin isoforms are increasingly protected against oxidative modifications in developing rat cardiomyocytes." Free Radical Biology & Medicine: no. 113 (2017): 224-235. DOI: 10.1016/j.freeradbiomed.2017.09.015. IF: 5.606
M. Szokol, D. Priksz, M. Bombicz, B. Varga, Á. Kovács, G. Fülöp, T. Csípő, A. Pósa, A. Tóth, Z. Papp, Z. Szilvássy, B. Juhász. "Long term osmotic mini pump treatment with alpha-MSH improves myocardial function in Zucker Diabetic Fatty rats." Molecules 22, no.10 (2017): pii: E1702. DOI: 10.3390/molecules22101702. IF: 2.861
V. Harjola, W. Mullens, M. Banaszewski, J. Bauersachs, Hans-Peter Brunner-La Rocca, O. Chioncel, S. Collins, W. Doehner, G. Filippatos, A. Flammer, V. Fuhrmann, M. Lainscak, J. Lassus, M. Legrand, J. Masip, C. Mueller, Z. Papp, J. Parissis, E. Platz, A. Rudiger, F. Ruschitzka, A. Schäfer, P. Seferovic, H. Skouri, M. Yilmaz, A. Mebazaa. "Organ dysfunction, injury and failure in acute heart failure: From pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)." European Journal of Heart Failure 19, no. 7 (2017): 821-836. DOI: 10.1002/ejhf.872. IF: 6.968
A. Patsalos, A. Pap, T. Varga, G. Trencsényi, G. Contreras, I. Garai, Z. Papp, B. Dezső, É. Pintye, L. Nagy. "In situ macrophage phenotypic transition is affected by altered cellular composition prior to acute sterile muscle injury." Journal of Physiology 595, no. 17 (2017): 5815-5842. DOI: 10.1113/JP274361. IF: 4.739
G. Pölzl, J. Altenberger, L. Baholli, P. Beltrán, A. Borbély, J. Comin-Colet, J. Delgado, F. Fedele, A. Fontana, F. Fruhwald, G. Giamouzis, G. Giannakoulas, M. Garcia-González, F. Gustafsson, K. Kaikkonen, M. Kivikko, J. Kubica, D. von Lewinski, I. Löfman, G. Malfatto, N. Manito, M. Martínez-Sellés, J. Masip, B. Merkely, F. Morandi, H. Mlgaard, F. Oliva, E. Pantev, Z. Papp, G. Perna, R. Pfister, V. Piazza, R. Bover, D. Rangel-Sousa, A. Recio-Mayoral, A. Reinecke, A. Rieth, T. Sarapohja, G. Schmidt, M. Seidel, S. Störk, B. Vrtovec, G. Wikström, P. Yerly, P. Pollesello. "Repetitive use of levosimendan in advanced heart failure: Need for stronger evidence in a field in dire need of a useful therapy." International Journal of Cardiology no. 243 (2017):389-395. DOI: 10.1016/j.ijcard.2017.05.081. IF: 6.189
J. Altenberger, F. Gustafsson, V. Harjola, K. Karason, D. Kindgen-Milles, M. Kivikko, G. Malfatto, Z. Papp, J. Parissis, P. Pollesello, G. Pölzl, C. Tschöpe. "Levosimendan in acute and advanced heart failure: An appraisal of the clinical database and evaluation of its therapeutic applications." Journal of Cardiovascular Pharmacology 71, no. 3 (2017):129-136. DOI: 10.1097/FJC.0000000000000533. IF: 2.247
C. Mátyás, B. Németh, A. Oláh, M. Török, M. Ruppert, D. Kellermayer, B. Barta, G. Szabó, G. Kökény, E. Horváth, B. Bódi, Z. Papp, B. Merkely, T. Radovits. "Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes." European Journal of Heart Failure 19, no. 3 (2017): 326-336. DOI: 10.1002/ejhf.711. IF: 6.968
L. Nagy, I. Gödény, P. Nánási, Á. Leskó, L. Balogh, V. Bánhegyi, B. Bódi, T. Csípő, A. Csongrádi, G. Fülöp, Á. Kovács, M. Lódi, Z. Papp. "A szív pozitív inotróp támogatása a miozin-aktivátor hatású omecamtiv-mecarbil segítségével." Cardiologica Hungarica no. 47 (2017): 145–152. DOI: 10.26430/CHUNGARICA.2017.47.2.145
Á. Kovács, J. Kalász, E. Pásztorné Tóth, A. Tóth, Z. Papp, N. Dhalla, J. Barta. "Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca2+-paradox rat hearts." Molecular and Cellular Biochemistry 403, no. 1-2 (2017): 57-68. DOI: 10.1007/s11010-017-2954-8 IF: 2.669
P. Cseplo, Z. Vamos, O. Torok, I. Ivic, A. Toth, A. Buki, A. Koller "Hemolyzed Blood Elicits a Calcium Antagonist and High CO2 Reversible Constriction via Elevation of [Ca2+] i in Isolated Cerebral Arteries" Journal of Neurotrauma 34, no. 2 (2017): 529-534. DOI: 10.1089/neu.2015.4365. IF: 5.19
B. Horváth, N. Szentandrássy, R. Veress, J. Almássy, J. Magyar, T. Bányász, A. Tóth Z. Papp, P. Nánási. "Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. " Naunyn-Schmiedebergs Archives of Pharmacology 390, no.12 (2017):1239-1246. DOI: 10.1007/s00210-017-1422-z. IF: 2.558
Z. Ungvari, M. N. Valcarcel-Ares, S. Tarantini, A. Yabluchanskiy, G. Fülöp, T. Kiss, A. Csiszar. "Connective tissue growth factor (CTGF) in age-related vascular pathologies." Geroscience. 39, no. 5-6 (2017):491-498. doi: 10.1007/s11357-017-9995-5. DOI: 10.1007/s11357-017-9995-5. IF: 2.123
G. Fülöp and A. Yabluchanskiy. "Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension." American Journal of Physiology Heart and Circulatory Physiology 313, no. 2 (2017): H251-H255. DOI: 10.1152/ajpheart.00320.2017. IF: 3.348
S. Tarantini, N. M. Valcarcel-Ares, A. Yabluchanskiy, Z. Springo, G. Fulop, N. Ashpole, T. Gautam, C. B. Giles, J. D. Wren, W. E. Sonntag, A. Csiszar, Z. Ungvari. "Insulin-like growth factor 1 deficiency exacerbates hypertension-induced cerebral microhemorrhages in mice, mimicking the aging phenotype." Aging Cell 16, no. 3 (2017): 469-479. DOI: 10.1111/acel.12583. IF: 6.714
M. Vecsernyes, M. Szokol, M. Bombicz, D. Priksz, R. Gesztelyi, G. Fulop, B. Varga, B. Juhasz, D. Haines, A. Tosaki. "Alpha-Melanocyte-stimulating Hormone Induces Vasodilation and Exerts Cardioprotection Through the Heme-Oxygenase Pathway in Rat Hearts." Journal of Cardiovascular Pharmacology 69, no. 5 (2017): 286-297. DOI: 10.1097/FJC.0000000000000472. IF: 2.247
Z. Ungvari, S. Tarantini, P. Hertelendy, M. N. Valcarcel-Ares, G. Fülöp, S. Logan, T. Kiss, E. Farkas A. Csiszar, A. Yabluchanskiy. "Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence." Geroscience 39, no. 1 (2017): 33-42. DOI: 10.1007/s11357-017-9964-z. IF: 2.123
S. Tarantini, G. Fulop, T. Kiss, E. Farkas, D. Zölei-Szénási, V. Galvan, P. Toth, A. Csiszar, Z. Ungvari, A. Yabluchanskiy. "Demonstration of impaired neurovascular coupling responses in TG2576 mouse model of Alzheimer's disease using functional laser speckle contrast imaging." Geroscience 39 (2017):465–473. DOI: 10.1007/s11357-017-9980-z. IF: 2.123
Z. Tucsek, M. N. Valcarcel-Ares, S. Tarantini, A. Yabluchanskiy, G. Fülöp, T. Gautam, A. Orock, A. Csiszar, F. Deak, Z. Ungvari. "Hypertension-induced synapse loss and impairment in synaptic plasticity in the mouse hippocampus mimics the aging phenotype: implications for the pathogenesis of vascular cognitive impairment." Geroscience 39 (2017):385–406 DOI: 10.1007/s11357-017-9981-y. IF: 2.123
A. Csiszar, S. Tarantini, G. Fülöp, T. Kiss, M. N. Valcarcel-Ares, V. Galvan, Z. Ungvari, A. Yabluchanskiy. "Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer's disease." Geroscience 39 (2017):359–372 DOI: 10.1007/s11357-017-9991-9. IF: 2.123
S. Tarantini, A. Yabluchanksiy, G. Fülöp, P. Hertelendy, M. N. Valcarcel-Ares, T. Kiss, J. M. Bagwell, D. O'Connor, E. Farkas, F. Sorond, A. Csiszar, Z. Ungvari. "Pharmacologically induced impairment of neurovascular coupling responses alters gait coordination in mice." Geroscience 39, no. 5-6 (2017): 601-614. DOI: 10.1007/s11357-017-0003-x. IF: 2.123
M. Fagyas "A Pitvarfibrilláció gyógyszeres kezelésének hatásai" Metabolizmus XV. évfolyam, 3. szám, 139-X (2017)